Cheng Jian, Liu Wenke, Zhang Si, Lei Ding, Hui Xuhui
Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China.
Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China.
World Neurosurg. 2017 Jul;103:248-256. doi: 10.1016/j.wneu.2017.03.144. Epub 2017 Apr 8.
Hemangioblastomas in the cerebellopontine angle (CPA) are uncommon and have rarely been reported. They may be easily misdiagnosed because of the atypical location and clinical and imaging features. The present study aimed to characterize clinical and radiologic features, treatment strategies, and outcomes in these rare lesions and to investigate various factors that may affect postoperative outcomes.
The medical records of patients with CPA hemangioblastomas who underwent surgery from 2003-2016 at the West China Hospital were reviewed retrospectively and statistically analyzed.
Twenty-three patients (14 males and 9 females) presented with CPA hemangioblastomas. Eight patients (34.8%) had von Hippel-Lindau (VHL) syndrome. Gross total resection was achieved in 22 patients (95.6%). The mean follow-up was 45.1 ± 36.2 months (range 3-144 months). After surgery, the symptoms improved in 18 cases (78.3%), remained unchanged in 3 cases (13%), and were aggravated in 2 cases (8.7%). Four patients showed local recurrence during follow-up (17.4%). Patients with cystic hemangioblastomas had a better neurologic improvement (P = 0.041) compared with patients with solid tumors. Furthermore, patients with maximal diameter of tumors >3 cm (P = 0.035) or solid tumors (P = 0.018) showed a higher incidence of postoperative complications. The local recurrence was correlated with VHL disease (P = 0.027).
Although hemangioblastomas of the CPA are challenging lesions to treat surgically, they can be removed safely when these lesions are appropriately diagnosed and treated. Patients with VHL disease are more likely to have a local recurrence. A regular follow-up is recommended to detect the local and distant recurrence, even if the clinical course is benign and the tumor is totally resected.
小脑脑桥角(CPA)血管母细胞瘤并不常见,鲜有报道。因其位置不典型以及临床和影像学特征,它们可能容易被误诊。本研究旨在描述这些罕见病变的临床和放射学特征、治疗策略及预后,并探究可能影响术后预后的各种因素。
回顾性分析2003年至2016年在华西医院接受手术的CPA血管母细胞瘤患者的病历,并进行统计分析。
23例患者(14例男性和9例女性)患有CPA血管母细胞瘤。8例患者(34.8%)患有冯·希佩尔-林道(VHL)综合征。22例患者(95.6%)实现了肿瘤全切除。平均随访时间为45.1±36.2个月(范围3至144个月)。术后,18例患者(78.3%)症状改善,3例患者(13%)症状不变,2例患者(8.7%)症状加重。4例患者在随访期间出现局部复发(17.4%)。与实性肿瘤患者相比,囊性血管母细胞瘤患者的神经功能改善更好(P = 0.041)。此外,肿瘤最大直径>3 cm的患者(P = 0.035)或实性肿瘤患者(P = 0.018)术后并发症发生率更高。局部复发与VHL病相关(P = 0.027)。
尽管CPA血管母细胞瘤是手术治疗具有挑战性的病变,但当这些病变得到恰当诊断和治疗时,可以安全切除。患有VHL病的患者更易发生局部复发。即使临床病程良性且肿瘤完全切除,也建议定期随访以检测局部和远处复发情况。